Life sciences industry veteran Gerald J. Vardzel Jr. has been named president and CEO of the University of Pittsburgh’s startup business incubator, LifeX Labs.
He replaces Evan Facher, director of Pitt’s Innovation Institute and LifeX board member, who’d been serving as interim CEO. Mr. Vardzel’s appointment was effective Jan. 4.
Mr. Vardzel, a Pitt grad, was most recently president and director at Predictive Oncology Inc., a company that uses artificial intelligence to develop personalized medical treatments. Previously, he served as president, CEO and board chairman of Helomics, a life science company that was acquired by Predictive Oncology in 2019.
He has been an executive in residence adviser at LifeX since July.
“Our region has the infrastructure and resources to have a meaningful impact in the near term, but we must leverage our existing strategic relationships while building new ones outside the region,” Mr. Vardzel said in a prepared statement.
South Side-based LifeX Labs helps life science entrepreneurs with attracting the capital investment and advice necessary to turn scientific and medical breakthroughs into therapies. The nonprofit Pitt program was formed in 2018.
Read More
Kris B. Mamula:kmamula@post-gazette.com or 412-263-1699




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.